4180339/2025-AQ. CENTRAL S1809 SACITUZUMAB-GOVITECAN 200 MG POWDER FOR SOLUTION FOR INJECTION

This tender concerns the procurement of Sacituzumab Govitecan, specifically the 200 mg formulation presented as a powder for solution for injection. The procedure is being conducted under a framework agreement, as stipulated by Article 258. The estimated base price for this procurement is €18,289.13. Sacituzumab Govitecan is a targeted therapy, often used in oncology, indicating that this tender is likely related to the healthcare sector, specifically the acquisition of specialized pharmaceutical products for patient treatment. The reference number for this tender is 4180339/2025-AQ. CENTRAL S1809. The use of a framework agreement suggests a streamlined procurement process, potentially for recurring needs or a pre-selected group of suppliers. Further details regarding the specific contracting authority, delivery locations, and detailed technical specifications would typically be found in the full tender documentation. This acquisition is crucial for ensuring the availability of advanced therapeutic options within the healthcare system. The tender aims to secure a reliable supply of this critical medication, adhering to the established procurement regulations and financial parameters.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 18,289.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.